SuperworthNatural Alternatives International NAII
- Market cap
- $26.8M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.2×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $142.5M
- +10% on a year ago
- Net margin
- −14.5%
- Free cash flow yield
- −47.2%
Natural Alternatives International trades at 0.2× sales. Its trailing earnings are negative, so it has no PE. Revenue was $142.5M over the last twelve months, up 10% on a year earlier with a −15% net margin.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $34M−21% | $25.2M−40% | $25.1M−23% | $29.5M−18% | $33.1M−2% | $34.1M+35% | $28.8M+14% | $33.9M+15% | $37.7M+14% | $34.8M+2% | $35.5M+23% | $34.5M+2% | |
| Cost of revenue | $30.8M−18% | $24.8M−31% | $23.2M−26% | $28.1M−9% | $30.9M+0% | $32.4M+31% | $26.9M+16% | $30.3M+8% | $33.3M+8% | $32.3M−0% | $35.1M+30% | $32.8M+8% |
| Gross profit | $3.1M−42% | $387K−94% | $1.9M+40% | $1.4M−73% | $2.3M−28% | $1.7M+331% | $1.8M−5% | $3.5M+149% | $4.4M+95% | $2.5M+49% | $383K−79% | $1.7M−51% |
| SG&A | $3.7M−4% | $3.9M+5% | $3.9M+0% | n/a | $4.1M+11% | $4.4M+14% | $3.9M+1% | n/a | $4.1M+0% | $4.3M−3% | $4.4M+12% | n/a |
| −$544K | −$3.5M | −$2M−22% | −$2.5M | −$1.8M+238% | −$2.8M−21% | −$2.1M+8% | −$1.9M−23% | $284K | −$1.8M−34% | −$4M+91% | −$13.2M+578% | |
| Interest expense | $93K+24% | $70K+27% | $74K−36% | $124K−40% | $178K+91% | $278K+297% | $246K+232% | $212K+71% | $226K+27% | $224K−19% | $270K+10% | $466K+120% |
| Pre-tax income | −$884K | −$3.8M | −$2M−29% | −$2.8M | −$2.4M+173% | −$2.9M−25% | −$2.6M+34% | −$2.8M+1% | −$199K−92% | −$2.3M−19% | −$4.2M+61% | −$13.5M+379% |
| −$189K | −$761K | −$390K−4% | −$907K | −$431K+128% | −$675K−11% | −$456K+17% | $4.4M | $92K | $224K | $68K | $46K−99% | |
| Net income | −$695K | −$3.1M | −$1.6M−34% | −$1.9M | −$2M+185% | −$2.2M−29% | −$2.2M+39% | −$7.2M+285% | −$291K−85% | −$2.6M+17% | −$4.3M+97% | −$13.5M+88% |
| −$0.12 | −$0.52 | −$0.27−34% | −$0.32 | −$0.33+175% | −$0.37−29% | −$0.37+37% | −$1.20+275% | −$0.05−85% | −$0.42+14% | −$0.72+95% | −$2.23+86% | |
| 5.9M−2% | 5.9M−0% | 5.9M+1% | 5.9M+1% | 5.9M+1% | 5.9M+1% | 5.9M+1% | 6M+2% | 6M+2% | 6M+2% | 6M+1% | 6.1M+1% |
EPS, diluted: 17 periods, Q4 FY11 to Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: 12 periods, Q4 FY11 to Q4 FY23: share-days: the 12-month average less the 9-month, weighted by days. 4 periods, Q4 FY19 to Q4 FY26: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Chemicals nearest Natural Alternatives International's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| NAIINatural Alternatives International | $26.8M | n/m | 9.7× | 0.2× | +10% | −14.5% | |
| BTMDbiote | $38.4M | 10.7× | 12.3× | 0.2× | −8% | 3.2% | |
| FTLFFitlife Brands | $78.4M | 13.5× | 15.3× | 0.8× | +61% | 6.2% | |
| NAGENiagen Bioscience | $192.3M | 13.5× | 27.0× | 1.5× | +11% | 12.4% | |
| Peer median | $78.4M | 13.5× | 15.3× | 0.8× | +11% | 6.2% |
More on Natural Alternatives International
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #10of 159Materials stocks with the lowest price to sales ratio
- #4of 43Chemicals stocks with the lowest price to sales ratio
Its groups
About
- Industry
- Chemicals
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .